Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma (Q81557844)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

5

Claes G Tropé

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

7

Jahn M Nesland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Hiep Phuc Dong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lilach Kleinberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ilvars Silins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Vivi Ann Flørenes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Björn Risberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ben Davidson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

84-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Tumor necrosis factor signaling.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Cell surface Death Receptor signaling in normal and cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Death and anti-death: tumour resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Fas engagement induces neurite growth through ERK activation and p35 upregulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

TRAIL Promotes the Survival and Proliferation of Primary Human Vascular Endothelial Cells by Activating the Akt and ERK Pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

The biological role of the Fas/FasL system during tumor formation and progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Ovarian cancer: strategies for overcoming resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Expression of Fas and FasL in human serous ovarian epithelial tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

The role of tumor necrosis factor receptors in tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Malignant effusions: from diagnosis to biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23140

7 January 2021

Identifiers

DOI

10.1002/CNCR.23140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17985388%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference